Publication | Closed Access

Comparisons of affinities, avidities, and complement activation of adalimumab, infliximab, and etanercept in binding to soluble and membrane tumor necrosis factor

InflammationComplement SystemAnti-inflammatoryAutoimmune DiseaseImmunologyPathologyChronic InflammationAutoimmunityImmunotherapyMedicineComplement Activation